Stem cell banking involves the process of collecting and storing stem cells from umbilical cord blood and tissue for future use in a stem cell bank. Stem cell therapy helps in treating various life-threatening diseases such as blood disorders, immune system diseases, and cancer. It has applications in regenerative medicine and tissue engineering. With increasing applications of stem cell therapy, the demand for stem cell storage is also growing.

The global Stem Cell Banking Market is estimated to be valued at US$ 534.81 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The popularity of stem cell banking services has increased significantly owing to rising government initiatives to support stem cell research activities. For instance, the U.S. government approved more than US$ 40 Mn in 2022 for the National Institutes of Health (NIH) to support various stem cell research programs. Such considerable investments are encouraging more families to store and donate cord blood stem cells for future therapeutic uses. Furthermore, increasing research efforts and patient awareness about potential clinical applications of stem cells in treating chronic diseases are augmenting the demand for stem cell preservation, thereby driving the stem cell banking market growth over the coming years.

Segment Analysis

The global stem cell banking market is dominated by the umbilical cord blood segment. Around 70% of total stem cell collections globally are from umbilical cord blood, as it is easily accessible and has several benefits over other sources like bone marrow. Umbilical cord blood contains stem cells that can treat over 80 diseases and also be used in regenerative medicine research. The rapid expansion of private and public cord blood banks across major markets like North America, Europe, and Asia Pacific has further boosted the umbilical cord blood segment in recent years.

Key Takeaways

The Global Stem Cell Banking Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The global Stem Cell Banking Market is estimated to be valued at US$ 534.81 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030.

Regional analysis indicates North America currently holds the largest share due to favorable reimbursement policies and increased awareness for stem cell therapeutics. The Asia Pacific region is set to exhibit the fastest growth rate owing to rising healthcare expenditure, growth in stem cell clinical trials, and government funding in countries like China, India, and South Korea.

Key players operating in the stem cell banking market are Cordlife Group Limited, Cryo-Cell International, ViaCord (a PerkinElmer company), Cryo-Save AG, Global Cord Blood Corporation, Lifecell International Pvt Ltd, cVault LLC, and Smart Cells International Ltd. The stem cell banking market is characterized by mergers and acquisitions among key players to expand geographically. For example, ViaCord merged with PerkinElmer in 2021 to leverage latter's network and expertise in reproductive genetic testing.

Get More Insights Here

https://www.newswirestats.com/stem-cell-banking-market-size-share-growth-outlook-2023/